Bond Biosciences, Inc. research brief

CIK 1824224 Copy CIK

Generated Nov. 3, 2026, 11:56 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: Parkville MO. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Oct. 5, 2026 · D/A · 0001014108-26-000053 · Source evidence

  Reported offering amount: 15000000 USD. Reported amount sold: 7614879 USD.

• June 4, 2026 · D/A · 0001014108-26-000032 · Source evidence

  Reported offering amount: 15000000 USD. Reported amount sold: 5927939 USD.

• April 8, 2026 · D · 0001014108-26-000021 · Source evidence

  Reported offering amount: 15000000 USD. Reported amount sold: 5342880 USD.

• Jan. 29, 2026 · D/A · 0001014108-26-000006 · Source evidence

  Reported offering amount: 4500000 USD. Reported amount sold: 4500000 USD.

• Dec. 8, 2025 · D/A · 0001014108-25-000082 · Source evidence

  Reported offering amount: 4500000 USD. Reported amount sold: 4065000 USD.

• Oct. 22, 2025 · D/A · 0001014108-25-000065 · Source evidence

  Reported offering amount: 4500000 USD. Reported amount sold: 3815000 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Bond Biosciences, Inc. research brief,” CIK 1824224, retrieved Nov. 3, 2026, 11:56 p.m.. Cite the specific accessions used. No amounts have been summed.